MedPath

Treatment of Complex PTSD

Conditions
Complex PTSDPhase-based treatmentTrauma-focusedEMDRSTAIRComplexe PTSSTraumagerichtGefaseerde behandeling
Registration Number
NL-OMON22074
Lead Sponsor
niversity of Amsterdam UvAUniversity of Groningen RuG
Brief Summary

1. Study protocol.<br> 2. Article about the results of the RCT in which phase-based treatment versus directe trauma-focused treatment are compared in patients with Complex PTSD.<br> 3. Article about cost-effectiveness of both treatments.<br> 4. Article about predictors and moderators in the treatment of Complex PTSD.<br> 5. Article about possible predictors of worse outcome and drop-out in the treatment of Complex PTSD.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
122
Inclusion Criteria

In order to be eligible to participate in this study, a patient must meet all of the following criteria: a) meeting the criteria for PTSD, according to the Clinical-Administered PTSD Scale for DSM-5 (CAPS-5; Weathers et al., 2013), b) having symptoms of Complex PTSD, c) reporting a history of repeated physical and/or sexual abuse by a caretaker or person in authority during childhood (before the age of 18), d) being in the age between 18 and 65 years, e) giving an informed consent for study participation.

Exclusion Criteria

A patient who meets any of the following criteria will be excluded from participation in this study: a) insufficient competence in speaking the Dutch language, b) high risk of suicidality assessed by the BDI-II (Beck, Steer, and Brown, 1996), c) currently in treatment for PTSD, d) severe alcohol or drug dependence or abuse, e) IQ under 80, and f) victim of ongoing physical and/or sexual abuse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of PTSD symptoms
Secondary Outcome Measures
NameTimeMethod
Secondary parameters include the presence of a PTSD diagnosis, severity of Complex PTSD symptoms and comorbid symptoms (i.e., anxiety, depression, general psychopathology), dissociation, health-related quality of life and drop out during treatment in both conditions.
© Copyright 2025. All Rights Reserved by MedPath